Drug Profile
Research programme: dengue vaccine - European Vaccine Initiative/Nagasaki University/Institut Pasteur
Latest Information Update: 28 Dec 2019
Price :
$50
*
At a glance
- Originator Institut Pasteur; Nagasaki University School of Medicine
- Class Dengue vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Dengue
Most Recent Events
- 28 Dec 2019 No recent reports of development identified for research development in Dengue(Prevention) in Japan (Parenteral)
- 10 Nov 2015 Early research in Dengue (Prevention) in Japan (Parenteral)
- 04 Nov 2015 European Vaccine Initiative, Nagasaki University and Institut Pasteur receives grant from the Global Health Innovative Technology Fund for dengue vaccine development